Outcomes of Overlapping Heterogeneous Drug-Eluting Stents Versus Homogeneous Drug-Eluting Stents for Diffuse Lesions in Small Coronary Arteries-Reference-Cited by-同舟云学术

Outcomes of Overlapping Heterogeneous Drug-Eluting Stents Versus Homogeneous Drug-Eluting Stents for Diffuse Lesions in Small Coronary Arteries

Published:2013-03-14 Issue:3 Volume:26 Page:264-270
ISSN:0896-4327
Container-title:Journal of Interventional Cardiology
language:en
Short-container-title:J. Int. Cardiol.

Author:

LIU SHENG WEN¹,QIAO SHU BIN¹,XU BO¹,HU FENG HUAN¹,CHEN JUE¹,YUAN JIN QING¹,WU YONG JIAN¹,YANG YUE JIN¹,CHEN JI LIN¹,GAO RUN LIN¹

Affiliation:

1. Cardiovascular Institute and Fuwai Hospital; Department of Cardiology; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing; China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1540-8183.2013.12023.x/fullpdf

Reference32 articles.

1. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization;Morice;N Engl J Med,2002

2. TAXUS I: Six- and twelve month results from a randomized, double-blind trial on a slow release paclitaxel-eluting stent for de novo coronary lesions;Grube;Circulation,2003

3. A hierarchical bayesian meta-analysis of randomized clinical trials of drug-eluting stents;Babapulle;Lancet,2004

4. Very long sirolimus-eluting stent implantation for de novo coronary lesions;Degertekin;Am J Cardiol,2004

5. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions;Kim;Catheter Cardiovasc Interv,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Prognosis Associated With the Use of Overlapping Stents With Homogenous Versus Heterogeneous Pharmacological Characteristics for the Treatment of Diffuse Coronary Artery Disease;Cardiovascular Revascularization Medicine;2020-11

2. Impact of chronic total occlusion lesion length on six-month angiographic and 2-year clinical outcomes;PLOS ONE;2018-11-13